Tables in dataset bio_sql_benchmark
AlzheimerDisease_CombinedGeneData_UUID
DrugGeneTargets_ComprehensiveAnnotations_updated
DrugTargets_IndicationsAndTherapeuticUses
NeurodegenerativeDiseases_SMR_Genes_Full
ParkinsonDisease_CompleteGeneData_No23andMe

Schema details for tables in dataset bio_sql_benchmark

Table: AlzheimerDisease_CombinedGeneData_UUID
Schema:
  - Name: UUID | Type: STRING | Mode: NULLABLE
  - Name: SNP | Type: STRING | Mode: NULLABLE
  - Name: A1 | Type: STRING | Mode: NULLABLE
  - Name: A2 | Type: STRING | Mode: NULLABLE
  - Name: freq | Type: FLOAT | Mode: NULLABLE
  - Name: b | Type: FLOAT | Mode: NULLABLE
  - Name: se | Type: FLOAT | Mode: NULLABLE
  - Name: p | Type: FLOAT | Mode: NULLABLE
  - Name: chr_37 | Type: INTEGER | Mode: NULLABLE
  - Name: bp_37 | Type: INTEGER | Mode: NULLABLE
  - Name: chr_38 | Type: INTEGER | Mode: NULLABLE
  - Name: bp_38 | Type: INTEGER | Mode: NULLABLE
  - Name: nearestGene | Type: STRING | Mode: NULLABLE

Randomly sampled rows from table:
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| UUID                               | SNP         | A1   | A2   |   freq |       b |     se |       p |   chr_37 |     bp_37 |   chr_38 |     bp_38 | nearestGene       |
+====================================+=============+======+======+========+=========+========+=========+==========+===========+==========+===========+===================+
| AD_combo_gene_notext_UUID_11383469 | rs17183567  | C    | G    | 0.0426 |  0.0075 | 0.0207 | 0.7185  |        8 | 106029978 |        8 | 105017750 | LRP12;ZFPM2       |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_7375656  | rs17162644  | C    | T    | 0.0777 | -0.0117 | 0.0153 | 0.4464  |        5 | 109401174 |        5 | 110065473 | LINC01848;TMEM232 |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_6735052  | rs187879548 | T    | G    | 0.02   |  0.0076 | 0.0329 | 0.8174  |        5 |  21460904 |        5 |  21460795 | GUSBP1            |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_12168103 | rs117252771 | G    | A    | 0.0011 |  0.4751 | 0.2196 | 0.03049 |        9 |  83849698 |        9 |  81234783 | LINC01507;TLE1    |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_4997351  | rs114502449 | G    | A    | 0.0289 |  0.0259 | 0.025  | 0.3003  |        3 | 193130822 |        3 | 193413033 | ATP13A4           |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_4049033  | rs552622584 | C    | T    | 0.0023 |  0.064  | 0.1064 | 0.5476  |        3 |  67160893 |        3 |  67110469 | KBTBD8;MIR4272    |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+
| AD_combo_gene_notext_UUID_15091721 | rs6580644   | A    | G    | 0.339  |  0.003  | 0.0086 | 0.7225  |       12 |  48306336 |       12 |  47912553 | VDR;TMEM106C      |
+------------------------------------+-------------+------+------+--------+---------+--------+---------+----------+-----------+----------+-----------+-------------------+


Table: DrugGeneTargets_ComprehensiveAnnotations_updated
Schema:
  - Name: UUID | Type: STRING | Mode: NULLABLE
  - Name: chemblIdentifier | Type: STRING | Mode: NULLABLE
  - Name: blackBoxWarning | Type: BOOLEAN | Mode: NULLABLE
  - Name: drugName | Type: STRING | Mode: NULLABLE
  - Name: drugMolecularType | Type: STRING | Mode: NULLABLE
  - Name: yearOfFirstApproval | Type: INTEGER | Mode: NULLABLE
  - Name: maxClinicalTrialPhase | Type: INTEGER | Mode: NULLABLE
  - Name: drugHasBeenWithdrawn | Type: BOOLEAN | Mode: NULLABLE
  - Name: drugIsApproved | Type: BOOLEAN | Mode: NULLABLE
  - Name: tradeNames_string | Type: STRING | Mode: NULLABLE
  - Name: drugSynonyms_string | Type: STRING | Mode: NULLABLE
  - Name: linkedDiseasesDrug_string | Type: STRING | Mode: NULLABLE
  - Name: linkedDiseasesCount | Type: INTEGER | Mode: NULLABLE
  - Name: newLinkedTargets_string | Type: STRING | Mode: NULLABLE
  - Name: numberLinkedTargets | Type: INTEGER | Mode: NULLABLE
  - Name: drugDescription | Type: STRING | Mode: NULLABLE
  - Name: drugActionType | Type: STRING | Mode: NULLABLE
  - Name: drugMechanismOfAction | Type: STRING | Mode: NULLABLE
  - Name: tradename_count | Type: INTEGER | Mode: NULLABLE
  - Name: synonyms_count | Type: INTEGER | Mode: NULLABLE

Randomly sampled rows from table:
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| UUID                    | chemblIdentifier   | blackBoxWarning   | drugName              | drugMolecularType   |   yearOfFirstApproval |   maxClinicalTrialPhase | drugHasBeenWithdrawn   | drugIsApproved   | tradeNames_string                                 | drugSynonyms_string                                                                                     | linkedDiseasesDrug_string                                                                                                                                            |   linkedDiseasesCount | newLinkedTargets_string                                                                         |   numberLinkedTargets | drugDescription                                                                                                                                                                                                                                  | drugActionType   | drugMechanismOfAction                                             |   tradename_count |   synonyms_count |
+=========================+====================+===================+=======================+=====================+=======================+=========================+========================+==================+===================================================+=========================================================================================================+======================================================================================================================================================================+=======================+=================================================================================================+=======================+==================================================================================================================================================================================================================================================+==================+===================================================================+===================+==================+
| DrugGeneTargets_v2_5699 | CHEMBL515914       | False             | Azaribine             | Small molecule      |                     0 |                       4 | True                   | True             | Triazure                                          | Azaribine, CB 304, CB-304, NSC-67239                                                                    |                                                                                                                                                                      |                     0 | UMPS (ENSG00000114491)                                                                          |                     1 | Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in at least one region.                                                                                                                                          | inhibitor        | Uridine 5'-monophosphate synthase inhibitor                       |                 1 |                4 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_4696 | CHEMBL4650514      | False             | Batoclimab            | Antibody            |                     0 |                       3 | False                  | False            |                                                   | Batoclimab, HBM-9161, HBM9161, HL161BKN, RVT-1401, RVT1401, Rvt-1401                                    | Autoimmune Thrombocytopenic Purpura (EFO_0007160), Graves Ophthalmopathy (EFO_1001466), Anemia, Hemolytic, Autoimmune (EFO_1001264), Myasthenia Gravis (EFO_0004991) |                     4 | FCGRT (ENSG00000104870)                                                                         |                     1 | Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications.                                                                                                                         | inhibitor        | IgG receptor FcRn large subunit p51 inhibitor                     |                 0 |                7 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_1190 | CHEMBL408          | False             | Troglitazone          | Small molecule      |                  1997 |                       4 | True                   | True             | Prelay, Rezulin, Romozin                          | CI-991, CS-045, GR-92132X, GR92132X, Rezulin, Troglitazone                                              | Diabetes Mellitus (EFO_0000400), Sarcoma (EFO_0000691)                                                                                                               |                     2 | PPARG (ENSG00000132170)                                                                         |                     1 | Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in at least one region.     | agonist          | Peroxisome proliferator-activated receptor gamma agonist          |                 3 |                6 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_3312 | CHEMBL4297863      | False             | Remtolumab            | Antibody            |                     0 |                       2 | False                  | False            |                                                   | A-1230717, ABT-122, Abt-122, Remtolumab                                                                 | Psoriatic Arthritis (EFO_0003778), Rheumatoid Arthritis (EFO_0000685)                                                                                                |                     2 | TNF (ENSG00000232810), IL17A (ENSG00000112115)                                                  |                     2 | Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.                                                                                                                          | inhibitor        | TNF-alpha inhibitor                                               |                 0 |                4 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_2878 | CHEMBL4650273      | False             | Setmelanotide Acetate | Protein             |                  2020 |                       4 | False                  | True             | Imcivree                                          | Setmelanotide acetate                                                                                   | Obesity (EFO_0001073)                                                                                                                                                |                     1 | MC4R (ENSG00000166603)                                                                          |                     1 | Protein drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for obesity.                                                                                                                             | agonist          | Melanocortin receptor 4 agonist                                   |                 1 |                1 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_5161 | CHEMBL4297147      | True              | Haloperidol Lactate   | Small molecule      |                  1967 |                       4 | False                  | True             | Haldol, Haloperidol intensol, Haloperidol lactate | Haloperidol lactate                                                                                     | Schizophrenia (MONDO_0005090), Agitation (HP_0000713), Schizoaffective Disorder (EFO_0005411)                                                                        |                     3 | HTR2A (ENSG00000102468), DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696) |                     4 | Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for schizophrenia and has 2 investigational indications. This drug has a black box warning from the FDA. | antagonist       | Serotonin 2a (5-HT2a) receptor antagonist                         |                 3 |                1 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+
| DrugGeneTargets_v2_1395 | CHEMBL1465         | False             | Phenprocoumon         | Small molecule      |                  1957 |                       4 | False                  | True             | Liquamar, Marcoumar                               | BS-7565, Fencumar, Marcumar, Phenprocoumarol, Phenprocoumarole, Phenprocoumon, Phenprocumone, RO-1-4849 | Melanoma (EFO_0000756), Recurrent Thrombophlebitis (HP_0004419), Venous Thrombosis (HP_0004936), Deep Vein Thrombosis (EFO_0003907)                                  |                     4 | VKORC1 (ENSG00000167397)                                                                        |                     1 | Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for recurrent thrombophlebitis and has 3 investigational indications.                                    | inhibitor        | Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor |                 2 |                8 |
+-------------------------+--------------------+-------------------+-----------------------+---------------------+-----------------------+-------------------------+------------------------+------------------+---------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+-------------------------------------------------------------------+-------------------+------------------+


Table: DrugTargets_IndicationsAndTherapeuticUses
Schema:
  - Name: UUID | Type: STRING | Mode: NULLABLE
  - Name: chemblId | Type: STRING | Mode: NULLABLE
  - Name: drugName | Type: STRING | Mode: NULLABLE
  - Name: tradeName | Type: STRING | Mode: NULLABLE
  - Name: drugType | Type: STRING | Mode: NULLABLE
  - Name: actionType | Type: STRING | Mode: NULLABLE
  - Name: targetType | Type: STRING | Mode: NULLABLE
  - Name: target | Type: STRING | Mode: NULLABLE
  - Name: approvedSymbol | Type: STRING | Mode: NULLABLE
  - Name: approvedName | Type: STRING | Mode: NULLABLE
  - Name: yearOfFirstApproval | Type: INTEGER | Mode: NULLABLE
  - Name: usan_year | Type: FLOAT | Mode: NULLABLE
  - Name: patent_no | Type: STRING | Mode: NULLABLE
  - Name: max_phase_for_ind | Type: FLOAT | Mode: NULLABLE
  - Name: mesh_id | Type: STRING | Mode: NULLABLE
  - Name: mesh_heading | Type: STRING | Mode: NULLABLE
  - Name: efo_id | Type: STRING | Mode: NULLABLE
  - Name: efo_term | Type: STRING | Mode: NULLABLE
  - Name: tradeNames_list | Type: STRING | Mode: NULLABLE
  - Name: tradename_count | Type: INTEGER | Mode: NULLABLE
  - Name: syns_list | Type: STRING | Mode: NULLABLE
  - Name: synonyms_count | Type: INTEGER | Mode: NULLABLE
  - Name: ct | Type: STRING | Mode: NULLABLE

Randomly sampled rows from table:
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| UUID                                     | chemblId     | drugName     | tradeName   | drugType       | actionType         | targetType            | target          | approvedSymbol   | approvedName                                                  |   yearOfFirstApproval |   usan_year | patent_no   |   max_phase_for_ind | mesh_id   | mesh_heading             | efo_id        | efo_term                | tradeNames_list                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |   tradename_count | syns_list                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |   synonyms_count | ct                              |
+==========================================+==============+==============+=============+================+====================+=======================+=================+==================+===============================================================+=======================+=============+=============+=====================+===========+==========================+===============+=========================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===================+======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==================+=================================+
| DrugTargetsIndication121923_text_462533  | CHEMBL220492 | Topiramate   | Qudexy Xr   | Small molecule | blocker            | protein family        | ENSG00000183873 | SCN5A            | sodium voltage-gated channel alpha subunit 5                  |                  1996 |        1987 | 9555005     |                   3 | D004828   | Epilepsies, Partial      | EFO:0004263   | partial epilepsy        | ['Epitomax', 'Eprontia', 'Qudexy xr', 'Topamax', 'Topamax sprinkleTopiramate', 'Trokendi xr']                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                 6 | ['(-)-topiramate', 'Epitoma', 'Eprontia', 'MCN-4853', 'Qudexy', 'RWJ-17021RWJ-17021-000', 'Sincronil', 'Topamac', 'Topimax', 'Topina', 'TopiramateTopomax', 'USL-255', 'USL255']                                                                                                                                                                                                                                                                                                                                                     |               13 | reached phase 3 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_1141300 | CHEMBL43452  | Pomalidomide | Pomalyst    | Small molecule | inhibitor          | protein complex       | ENSG00000113851 | CRBN             | cereblon                                                      |                  2013 |        2006 | 8735428*PED |                   1 | D002051   | Burkitt Lymphoma         | EFO:0000309   | Burkitts lymphoma       | ['Imnovid', 'Pomalyst']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                 2 | ['Actimid', 'CC-4047', 'IMID 3', 'IMID-3', 'Pomalidomide']                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                5 | reached phase 1 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_516984  | CHEMBL220492 | Topiramate   | Trokendi Xr | Small molecule | positive modulator | protein complex group | ENSG00000022355 | GABRA1           | gamma-aminobutyric acid type A receptor subunit alpha1        |                  1996 |        1987 | 8663683     |                   3 | D016540   | Smoking Cessation        | EFO:0004319   | smoking cessation       | ['Epitomax', 'Eprontia', 'Qudexy xr', 'Topamax', 'Topamax sprinkleTopiramate', 'Trokendi xr']                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                 6 | ['(-)-topiramate', 'Epitoma', 'Eprontia', 'MCN-4853', 'Qudexy', 'RWJ-17021RWJ-17021-000', 'Sincronil', 'Topamac', 'Topimax', 'Topina', 'TopiramateTopomax', 'USL-255', 'USL255']                                                                                                                                                                                                                                                                                                                                                     |               13 | reached phase 3 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_360574  | CHEMBL723    | Carvedilol   | Coreg Cr    | Small molecule | antagonist         | protein family        | ENSG00000170214 | ADRA1B           | adrenoceptor alpha 1B                                         |                  1995 |        1988 | 8101209     |                   2 | D007674   | Kidney Diseases          | EFO:0003086   | kidney disease          | ['Carvedilol', 'Coreg', 'Coreg CR', 'Eucardic 12.5', 'Eucardic 25Eucardic 3.125', 'Eucardic 6.25']                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                 6 | ['BM 14.190', 'BM-14-190', 'BM-14.190', 'BM-14190', 'C07AG02', 'CarvedilolCoronis', 'DQ-2466', 'Dilatrend', 'Dimitone', 'Eucardic', 'Korvasan', 'KredexNSC-758694', 'SKF-105517', 'Talliton']                                                                                                                                                                                                                                                                                                                                        |               14 | reached phase 2 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_875403  | CHEMBL1059   | Pregabalin   | Lyrica Cr   | Small molecule | modulator          | protein complex group | ENSG00000151062 | CACNA2D4         | calcium voltage-gated channel auxiliary subunit alpha2delta 4 |                  2004 |        1997 | 9144559*PED |                   1 | D002294   | Carcinoma, Squamous Cell | EFO:0000707   | squamous cell carcinoma | ['Alzain', 'Axalid', 'Lecaent', 'Lyrica', 'Lyrica cr', 'Pregabalin', 'Rewisca']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                 7 | ['CI-1008', 'NSC-759256', 'PD-144723', 'Pregabalin', 'Pregabalin mylanPregabalin sandoz', 'Pregabalin sandoz gmbh', 'Pregabalin zentivaVronogabic', 'YNP-1807']                                                                                                                                                                                                                                                                                                                                                                      |                8 | reached phase 1 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_910     | CHEMBL428647 | Paclitaxel   | Abraxane    | Small molecule | inhibitor          | protein complex group | ENSG00000188229 | TUBB4B           | tubulin beta 4B class IVb                                     |                  1992 |        1993 | 8138229     |                   3 | D013964   | Thyroid Neoplasms        | MONDO:0002108 | thyroid cancer          | ['Abraxane', 'Pacitaxel', 'Paclitaxel', 'Paxene', 'Taxol', 'Taxol 100']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                 6 | ['(-)-paclitaxel', 'ABI-007', 'ABI-007 COMPONENT PACLITAXEL', 'BMS 181339-01BMS-181339-01', 'Capxol', 'Cyclopax', 'DHP 107', 'DHP-107', 'EbetaxelEmpac', 'Endotag 1', 'Genaxol', 'Genetaxyl', 'Genexol', 'Genexol-pmIntaxel', 'Lep-etu', 'MBT 0206', 'MBT-0206', 'Mitotax', 'NK 105', 'NK-105NSC-125973', 'Oncogel', 'Onxal', 'Onxol', 'Pacliex', 'PaclitaxelPaclitaxel (taxus canadensis)', 'Paclitaxol', 'Plaxicel', 'QW-8184Taxalbin', 'Taxol', 'Taxol a', 'Taxus', 'Taxus liberte', 'Taxus stentTocosol paclitaxel', 'Yewtaxan'] |               34 | reached phase 3 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+
| DrugTargetsIndication121923_text_384144  | CHEMBL679    | Epinephrine  | Auvi-Q      | Small molecule | agonist            | protein family        | ENSG00000188778 | ADRB3            | adrenoceptor beta 3                                           |                  1976 |             | 10842938    |                   4 | D005901   | Glaucoma                 | EFO:0000516   | glaucoma                | ['Adren co', 'Adrenaclick', 'Adrenalin', 'Ana-Kit', 'Ana-guard', 'AnapenAnaphylactic shock drug kit', 'Asma-vydrin', 'Asthmahaler', 'Auvi-qBronkaid mist', 'Brovon', 'Emerade', 'Epi e z pen jr', 'EpinephrineEpinephrine (copackaged)', 'Epipen', 'Epipen e z pen', 'Epipen jrEpipen jr.', 'Eppy', 'Gppe inh soln', 'Jext', 'Medihaler-epi', 'PrimatenePrimatene mist', 'Riddobron', 'Riddofan', 'Rybarvin', 'SimpleneSoln made to rybarvin for', 'Sus-Phrine', 'Sus-Phrine Sulfite-FreeSus-phrine sulfite free', 'Symjepi', 'Twinject 0.15', 'Twinject 0.3'] |                30 | ['(-)-(r)-epinephrine', '(-)-epinephrine', 'Adrenaline', 'AdrenalinumEpinephrine', 'Epinephrine hcl', 'Epinephrine hydrochlorideEpinephrinum', 'Glauposine', 'L-epinephrine hydrochlorideLevo-methylaminoethanolcatechol', 'NSC-62786', 'NephridineRacepinefrine hydrochloride, (r)-', 'Racepinefrine, (r)-Sus-phrine sulphite-free', 'Susphrine', 'Tonogen', 'Twinject']                                                                                                                                                            |               14 | reached phase 4 clinical trials |
+------------------------------------------+--------------+--------------+-------------+----------------+--------------------+-----------------------+-----------------+------------------+---------------------------------------------------------------+-----------------------+-------------+-------------+---------------------+-----------+--------------------------+---------------+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+---------------------------------+


Table: NeurodegenerativeDiseases_SMR_Genes_Full
Schema:
  - Name: UUID | Type: STRING | Mode: NULLABLE
  - Name: Omic | Type: STRING | Mode: NULLABLE
  - Name: Disease | Type: STRING | Mode: NULLABLE
  - Name: probeID | Type: STRING | Mode: NULLABLE
  - Name: ProbeChr | Type: INTEGER | Mode: NULLABLE
  - Name: Gene | Type: STRING | Mode: NULLABLE
  - Name: Probe_bp | Type: INTEGER | Mode: NULLABLE
  - Name: topSNP | Type: STRING | Mode: NULLABLE
  - Name: topSNP_chr | Type: INTEGER | Mode: NULLABLE
  - Name: topSNP_bp | Type: INTEGER | Mode: NULLABLE
  - Name: A1 | Type: STRING | Mode: NULLABLE
  - Name: A2 | Type: STRING | Mode: NULLABLE
  - Name: Freq | Type: FLOAT | Mode: NULLABLE
  - Name: b_GWAS | Type: FLOAT | Mode: NULLABLE
  - Name: se_GWAS | Type: FLOAT | Mode: NULLABLE
  - Name: p_GWAS | Type: FLOAT | Mode: NULLABLE
  - Name: b_eQTL | Type: FLOAT | Mode: NULLABLE
  - Name: se_eQTL | Type: FLOAT | Mode: NULLABLE
  - Name: p_eQTL | Type: FLOAT | Mode: NULLABLE
  - Name: b_SMR | Type: FLOAT | Mode: NULLABLE
  - Name: se_SMR | Type: FLOAT | Mode: NULLABLE
  - Name: p_SMR | Type: FLOAT | Mode: NULLABLE
  - Name: p_SMR_multi | Type: FLOAT | Mode: NULLABLE
  - Name: p_HEIDI | Type: FLOAT | Mode: NULLABLE
  - Name: nsnp_HEIDI | Type: FLOAT | Mode: NULLABLE
  - Name: topRSID | Type: STRING | Mode: NULLABLE
  - Name: Omic_type | Type: STRING | Mode: NULLABLE
  - Name: Omic_tissue | Type: STRING | Mode: NULLABLE
  - Name: Disease_name | Type: STRING | Mode: NULLABLE
  - Name: Source | Type: STRING | Mode: NULLABLE
  - Name: func_sig | Type: STRING | Mode: NULLABLE

Randomly sampled rows from table:
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| UUID                                  | Omic                          | Disease   | probeID         |   ProbeChr | Gene     |   Probe_bp | topSNP      |   topSNP_chr |   topSNP_bp | A1   | A2   |      Freq |     b_GWAS |   se_GWAS |     p_GWAS |    b_eQTL |   se_eQTL |      p_eQTL |      b_SMR |    se_SMR |     p_SMR |   p_SMR_multi |   p_HEIDI |   nsnp_HEIDI | topRSID     | Omic_type              | Omic_tissue       | Disease_name                   | Source      | func_sig                     |
+=======================================+===============================+===========+=================+============+==========+============+=============+==============+=============+======+======+===========+============+===========+============+===========+===========+=============+============+===========+===========+===============+===========+==============+=============+========================+===================+================================+=============+==============================+
| NDD_SMR_genes_all_update_text_736656  | blood_mcrae                   | ALS       | cg06635133      |         16 | XYLT1    |   17528276 | rs116002100 |           16 |    17541132 | C    | T    | 0.0429448 | -0.0551    | 0.0349    | 0.114383   |  0.83825  | 0.0724692 | 6.05796e-31 | -0.0657322 | 0.0420204 | 0.117749  |    0.120951   |  0.581601 |            9 | rs116002100 | Whole Blood mQTL       | Whole Blood       | Amyotrophic Lateral Sclerosis  | mcrae       | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_607642  | blood_mcrae                   | AD        | cg05106294      |         11 | DKK3     |   12031097 | rs4391796   |           11 |    12048674 | C    | T    | 0.186094  | -0.0034    | 0.0101    | 0.736393   | -0.22764  | 0.039233  | 6.54252e-09 |  0.0149359 | 0.0444429 | 0.736819  |    0.493951   |  0.347764 |           10 | rs4391796   | Whole Blood mQTL       | Whole Blood       | Alzheimer's Disease            | mcrae       | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_892609  | blood_mcrae                   | LBD       | cg16425038      |         14 | REC8     |   24641194 | rs10467733  |           14 |    24645010 | T    | C    | 0.270961  |  0.0356181 | 0.0407215 | 0.381751   |  0.232645 | 0.0349399 | 2.76757e-11 |  0.153101  | 0.176541  | 0.385819  |    0.748906   |  0.589586 |            9 | rs10467733  | Whole Blood mQTL       | Whole Blood       | Lewy Body Dementia             | mcrae       | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_1216270 | psychEncode_prefrontal_cortex | FTD       | ENSG00000006607 |          2 | FARP2    |  242295658 | rs12469591  |            2 |   242278559 | A    | T    | 0.810838  | -0.10436   | 0.1083    | 0.335237   |  0.251859 | 0.019566  | 6.44691e-38 | -0.414359  | 0.431206  | 0.336587  |    0.465705   |  0.540737 |           20 | rs12469591  | Prefrontal Cortex eQTL | Prefrontal Cortex | Frontotemporal Dementia        | psychEncode | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_715560  | blood_mcrae                   | ALS       | cg02884928      |         14 | AKT1     |  105251610 | rs2494751   |           14 |   105262961 | G    | A    | 0.093047  |  0.0717    | 0.0275    | 0.00912666 | -1.02235  | 0.0579427 | 1.12862e-69 | -0.0701325 | 0.0271909 | 0.0099011 |    0.00300949 |  0.546274 |           17 | rs2494751   | Whole Blood mQTL       | Whole Blood       | Amyotrophic Lateral Sclerosis  | mcrae       | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_1103886 | blood_mcrae                   | PSP       | cg19152809      |          6 | WDR27    |  170047908 | rs713367    |            6 |   170205573 | C    | T    | 0.0807771 |  0.1248    | 0.1021    | 0.221582   | -0.582362 | 0.0577393 | 6.36725e-24 | -0.2143    | 0.176603  | 0.224957  |    0.109124   |  0.499656 |            7 | rs713367    | Whole Blood mQTL       | Whole Blood       | Progressive supranuclear palsy | mcrae       | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+
| NDD_SMR_genes_all_update_text_1326288 | Nerve_Tibial                  | PD        | ENSG00000203805 |         10 | PPAPDC1A |  122216466 | rs12771003  |           10 |   122332345 | G    | C    | 0.572597  | -0.0419    | 0.0226    | 0.0637417  | -0.568582 | 0.042716  | 2.00459e-40 |  0.0736921 | 0.0401317 | 0.0663198 |    0.06577    |  0.692629 |           20 | rs12771003  | Tibial Nerve eQTL      | Tibial Nerve      | Parkinson's Disease            | GTEx        | not functionally significant |
+---------------------------------------+-------------------------------+-----------+-----------------+------------+----------+------------+-------------+--------------+-------------+------+------+-----------+------------+-----------+------------+-----------+-----------+-------------+------------+-----------+-----------+---------------+-----------+--------------+-------------+------------------------+-------------------+--------------------------------+-------------+------------------------------+


Table: ParkinsonDisease_CompleteGeneData_No23andMe
Schema:
  - Name: UUID | Type: STRING | Mode: NULLABLE
  - Name: SNP | Type: STRING | Mode: NULLABLE
  - Name: A1 | Type: STRING | Mode: NULLABLE
  - Name: A2 | Type: STRING | Mode: NULLABLE
  - Name: freq | Type: FLOAT | Mode: NULLABLE
  - Name: b | Type: FLOAT | Mode: NULLABLE
  - Name: se | Type: FLOAT | Mode: NULLABLE
  - Name: p | Type: FLOAT | Mode: NULLABLE
  - Name: chr_37 | Type: INTEGER | Mode: NULLABLE
  - Name: bp_37 | Type: INTEGER | Mode: NULLABLE
  - Name: chr_38 | Type: INTEGER | Mode: NULLABLE
  - Name: bp_38 | Type: INTEGER | Mode: NULLABLE
  - Name: nearestGene | Type: STRING | Mode: NULLABLE

Randomly sampled rows from table:
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| UUID                                 | SNP         | A1   | A2   |   freq |       b |     se |      p |   chr_37 |     bp_37 |   chr_38 |     bp_38 | nearestGene        |
+======================================+=============+======+======+========+=========+========+========+==========+===========+==========+===========+====================+
| PDno23andme_full_gene_notext_1636168 | rs2697318   | C    | A    | 0.2106 | -0.0058 | 0.0274 | 0.8332 |        2 | 198092910 |        2 | 197228186 | ANKRD44            |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_3792086 | rs4912913   | T    | C    | 0.4673 |  0.0138 | 0.024  | 0.565  |        5 | 142818306 |        5 | 143438741 | NR3C1;MIR5197      |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_4061454 | rs4786183   | C    | T    | 0.4447 | -0.0425 | 0.0224 | 0.0574 |       16 |   7619187 |        0 |         0 | RBFOX1             |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_5508872 | rs35059860  | C    | T    | 0.015  | -0.0015 | 0.1211 | 0.9901 |       10 |  48320768 |        0 |         0 | ANXA8;LOC107001062 |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_140908  | rs140246288 | T    | C    | 0.0161 | -0.0494 | 0.0805 | 0.5392 |       15 |  42422726 |       15 |  42130528 | PLA2G4D;PLA2G4F    |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_6378348 | rs12913637  | C    | G    | 0.44   |  0.0034 | 0.0229 | 0.8817 |       15 |  29451226 |       15 |  29159023 | FAM189A1           |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+
| PDno23andme_full_gene_notext_2742201 | rs74652879  | T    | A    | 0.0161 | -0.0962 | 0.091  | 0.2904 |        4 |  26864316 |        4 |  26862694 | STIM2              |
+--------------------------------------+-------------+------+------+--------+---------+--------+--------+----------+-----------+----------+-----------+--------------------+

